[Acute lupus erythematosus induced by procainamide].
D000367:Age Factors; D000974:Antibodies, Antinuclear / Q000032:analysis; D001168:Arthritis; D005334:Fever; D006331:Heart Diseases / Q000188:drug therapy; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009437:Neuralgia; D009504:Neutrophils / Q000032:analysis; D010493:Pericarditis; D010996:Pleural Effusion; D011342:Procainamide / Q000009:adverse effects* / Q000627:therapeutic use; D012737:Sex Factors
D000974:Antibodies, Antinuclear; D011342:Procainamide
Lupus érythémateux aigu induit par la procaïnamide.